questionText: To ask the Secretary of State for Health and Social Care, how the Medicines and Healthcare products Regulatory Agency plans to improve the (a) monitoring and (b) reporting of adverse effects related to weight loss drugs; and what systems are in place to ensure that (i) patients and (ii) healthcare providers can report those effects.
answerText: The Yellow Card scheme collects reports of suspected adverse effects for all healthcare products including weight loss drugs. Reporting is open to all healthcare professionals and members of the public through a variety of methods including online, via th...
heading: Obesity: Drugs